rheumatoid arthritis
Myriad Genetics Settles Anti-Kickback Lawsuit Related to Vectra DA
Myriad will pay $45.25 million to the federal and California state governments and $2.75 million to the whistleblower in exchange for dismissal of the case and all claims against it.
The company is hoping to gain a local coverage determination from CMS this year as it solidifies data for its first assay and works on building out a larger menu.
Scipher Medicine Nabs $110M in Financing
The company is advancing a pipeline of RNA-based immune disease assays, spearheaded by its PrismRA test to guide therapy for rheumatoid arthritis.
Exagen, QMUL to Develop Molecular Signatures for Rheumatoid Arthritis Therapy Selection
The assays under development will segment patients according to gene expression in their synovial tissue biopsies to personalize therapy selection.
Zeus Scientific Acquires Rights to Synthetic Peptides From Sheba Medical Center
Zeus intends to use the peptides to develop a new generation of immunoassays that will measure autoantibodies to diagnose rheumatoid arthritis.